Health Care/Hospital APAC News & Press Release Distribution

UOB intensifies COVID-19 safety measures by applying self-disinfecting coating at high-touch areas within its branches island-wide

SINGAPORE, June 1, 2020 /PRNewswire/ -- United Overseas Bank (UOB) today announced that it has enhanced the precautionary measures within its branches with the application of a commercial grade self-disinfecting coating at high-touch areas including branch counters and meeting areas. The initiati...

2020-06-01 11:53 4406

UOB intensifies COVID-19 safety measures by applying self-disinfecting coating at high-touch areas within its branches island-wide

Uniview Temperature Screening Solutions Help Thailand Government to Fight Against COVID 19

BANGKOK, June 1, 2020 /PRNewswire/ -- In May, 2020, through the Ministry of Education, Ministry of Technology, and Prime Ministry's Office, Uniview provided enhanced temperature screening solutions and products, including CW-180, OET-213H-BTS1, and other Heat-Tracker series products, to help the ...

2020-06-01 11:34 2478

NCH Asia Pacific announces the specialized 'NCH Disinfection Program' to keep NCH customers' business running and protecting their customers

SINGAPORE, June 1, 2020 /PRNewswire/ -- NCH Asia Pacific, a global leader in industrial and commercial maintenance products and services since 1919, announced that it has launched a new'NCH Disinfection Program' to help businesses stay safe during the pandemic. COVID-19 haschanged lives and has ...

2020-06-01 09:00 1870

NCH Asia Pacific announces the specialized 'NCH Disinfection Program' to keep NCH customers' business running and protecting their customers

Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal

SYDNEY, June 1, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share a poster presentation of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most comm...

2020-06-01 08:45 4930

Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)

SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced ...

2020-06-01 07:30 4837

Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma

SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the research results of TY...

2020-06-01 07:30 4825

Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the results of TYVYT® (sin...

2020-06-01 07:30 5100

Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT® (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma

SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announce...

2020-06-01 07:30 4763

Establishment of the Blue Apple New Frontier Healthcare Fund

HONG KONG, June 1, 2020 /PRNewswire/ -- New Frontier Capital Management Hong Kong has signed a collaborative MOU with Blue Apple Partners to establish the "Blue Apple New Frontier Healthcare Fund" (tentative name; the "Fund") to be jointly managed by both parties. Blue Apple Partners is a h...

2020-06-01 07:00 3558

Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients

SINGAPORE, May 30, 2020 /PRNewswire/ -- According to the data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on29 May 2020, researchers at Samsung Medical Center inSeoul, Korea, have found useful prognostic information beyond actionable biomarkers when the Guardant36...

2020-05-30 19:00 3151

The 2nd Singapore-China Joint Meeting on COVID-19

Joint Press Statement SINGAPORE, May 30, 2020 /PRNewswire/ -- On 28 May 2020, Permanent Secretary Chee Wee Kiong of the Ministry of Foreign Affairs of the Republic of Singapore and Vice Minister Luo Zhaohui of the Ministry of Foreign Affairs ofthe People's Republic of China co-chaired the 2nd Ch...

2020-05-30 00:56 3526

New England Journal of Medicine Publishes Primary Analysis of VISION Data for Tepotinib in Advanced NSCLC with METex14 Skipping Alterations

DARMSTADT, Germany, May 29, 2020 /PRNewswire/ -- Merck, a leading science and technology company, today announced that updated data from the ongoing, single-arm Phase II VISION study evaluating tepotinib* as a single agent in patients with advanced non-small cell lung cancer (NSCLC) withMET exon ...

2020-05-29 20:33 3085

Zlatko Rihter Appointed New CEO of Moelnlycke

GOTHENBURG, Sweden, May 29, 2020 /PRNewswire/ -- Zlatko Rihter has been appointed President and CEO of the medical solutions company, Moelnlycke Health Care AB. Zlatko Rihter is a Swedish citizen and currently President and CEO of Sweden -based CellaVision, a world-leading provider of digital sol...

2020-05-29 15:13 2549

Jakarta-Based Home of Wellbeing Rumah Remedi Held #stayathome Meditations During the Pandemic

* Regular meditation sessions were free of charge from mid of March until the end ofApril 2020. * By migrating the sessions from offline to online, Rumah Remedi managed to reach individuals residing in various places inIndonesia who needed help during the pandemic. JAKARTA, Indonesia, May 29,...

2020-05-29 12:41 3041

Jakarta-Based Home of Wellbeing Rumah Remedi Held #stayathome Meditations During the Pandemic

Thailand's Economic Front in Fighting COVID-19

BANGKOK, May 29, 2020 /PRNewswire/ -- Thailand has performed well in containing the COVID-19 outbreak and mitigating its impact. Since27 April 2020, the number of new COVID-19 cases has increased only slightly, while some days saw no new cases at all. About 96 per cent of those infected have full...

2020-05-29 12:20 7246

Thailand's Economic Front in Fighting COVID-19

Overcoming Challenges to Offline Education, Mysavvytutor Advances with New On-Demand App

SINGAPORE, May 29, 2020 /PRNewswire/ — According to a United Nations' report , theCOVID-19 outbreak has disrupted education for over 290.5 million students globally. ASinga...

2020-05-29 10:00 4075

Ping An Voyager Fund Leads Investment in PlusDental to Enhance Modern Dentistry in Europe

HONG KONG and SHANGHAI, May 29, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) is delighted to announce that its fintech and healthtech investment arm Ping An Global Voyager Fund has invested in digital dentistry pl...

2020-05-29 09:48 14548

Zai Lab Announces Positive Topline Results from the NORA Phase 3 Study of ZEJULA® as Maintenance Therapy for Chinese Patients with Platinum-sensitive, Recurrent Ovarian Cancer

SHANGHAI and SAN FRANCISCO, May 29, 2020 /PRNewswire/ -- Zai Lab Limited ("Zai Lab") (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced positive topline results from the NORA study, the Phase 3 randomized, double-blind, placebo-controlled, study of ZEJULA (n...

2020-05-29 07:05 3293

Endofotonics Raises S$12 million in Series B Funding for the Commercialization of its AI Powered Medical Device to Support Clinicians in the Real Time Detection of Early Stomach Cancer

SINGAPORE, May 29, 2020 /PRNewswire/ -- Endofotonics announced earlier today that it has secured an investment ofS$12 million led by eminent healthcare investors Mr Tony Tan Choon Keat, Chairman of Singapore Medical Group (SMG) and Founding Managing Director of Par...

2020-05-29 07:00 4483

Shinshu University and Toshiba Develop Tumor-Tropic Liposome Technology that Carries Therapeutic Genes into Cancer Cells

TOKYO, May 28, 2020 /PRNewswire/ -- Toshiba Corporation (TOKYO: 6502, hereinafter "Toshiba") and a team led by ProfessorYozo Nakazawa at the Department of Pediatrics, Shinshu University, (hereinafter "Shinshu University"), have together developed a "tumor-tropic liposome technology" for gene the...

2020-05-28 23:00 7388